Harrow (HROW) Receivables - Net (2014 - 2026)
Harrow (HROW) posted Receivables - Net of $118.6 million for Q2 2026, up 17.08% on a QoQ basis from $101.3 million in Q1 2026, and up 50.41% year-over-year from $78.8 million in Q2 2025.
Analysis
Harrow (HROW) Receivables - Net (2014 - 2026) Analysis & Trends
Harrow has reported Receivables - Net for 13 years, with the latest figure at $118.6 million in Q2 2026.
- On a quarterly basis, Receivables - Net rose 50.41% year-over-year to $118.6 million in Q2 2026; TTM through Jun 2026 was $118.6 million, a 50.41% increase from a year earlier, with the FY2025 full-year figure at $110.9 million, down 4.71% from the prior year.
- Receivables - Net was $118.6 million for Q2 2026 at Harrow, up from $101.3 million in the prior quarter.
- The five-year high for Receivables - Net was $118.6 million in Q2 2026, with the low at $779000.0 in Q4 2022.
- Average Receivables - Net over 5 years is $50.0 million, with a median of $40.8 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Receivables - Net soared 1857.12% in 2023, then decreased 4.71% in 2025.
- Over 5 years, Receivables - Net stood at $779000.0 in 2022, then jumped by 1857.12% to $15.2 million in 2023, then jumped by 663.3% to $116.4 million in 2024, then dropped by 4.71% to $110.9 million in 2025, then increased by 6.91% to $118.6 million in 2026.
- The last three Receivables - Net figures came in at $118.6 million (Q2 2026), $101.3 million (Q1 2026), and $110.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Harrow | 1.41 Bn | 1.33 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.56 Mn |
| Mar 31, 2026 | 101.26 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Sep 30, 2025 | 77.60 Mn |
| Jun 30, 2025 | 78.82 Mn |
| Mar 31, 2025 | 77.06 Mn |
| Dec 31, 2024 | 116.37 Mn |
| Sep 30, 2024 | 53.73 Mn |
| Jun 30, 2024 | 52.73 Mn |
| Mar 31, 2024 | 28.96 Mn |
| Dec 31, 2023 | 15.25 Mn |
| Sep 30, 2023 | 18.47 Mn |
| Jun 30, 2023 | 18.26 Mn |
| Mar 31, 2023 | 12.11 Mn |
| Dec 31, 2022 | 779,000.00 |
| Sep 30, 2022 | 6.74 Mn |
| Jun 30, 2022 | 6.76 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 4.16 Mn |